Raymond James Financial’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.9M Buy
964,706
+306,031
+46% +$4.54M ﹤0.01% 1754
2025
Q4
$9.91M Buy
658,675
+232,026
+54% +$3.48M ﹤0.01% 1975
2025
Q3
$6.15M Sell
426,649
-283,476
-40% -$4.03M ﹤0.01% 2323
2025
Q2
$10.1M Sell
710,125
-8,595
-1% -$123K ﹤0.01% 1858
2025
Q1
$10.7M Sell
718,720
-36,102
-5% -$565K ﹤0.01% 1765
2024
Q4
$10.9M Buy
+754,822
New +$11.7M ﹤0.01% 1786

Other funds holding BMEZ

Raymond James Financial's BMEZ Position: Q1 2026 in Review

Raymond James Financial increased its BlackRock Health Sciences Trust II (BMEZ) stake by 46% in Q1 2026, buying an estimated $4.54M and bringing the position to 964,706 shares worth $13.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1754.

Raymond James Financial first reported a position in BMEZ in Q4 2024 and has held it in 6 quarters since. 88 funds tracked by Wall St. Rank hold BMEZ as of Q1 2026.

  • Raymond James Financial held 964,706 shares of BlackRock Health Sciences Trust II worth $13.9M as of Q1 2026.
  • Raymond James Financial bought 306,031 BlackRock Health Sciences Trust II shares in Q1 2026, an estimated $4.54M.
  • BlackRock Health Sciences Trust II made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #1754 holding.
  • Raymond James Financial first reported a position in BlackRock Health Sciences Trust II in Q4 2024 and has held it in 6 quarters since.
  • 88 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.